ArticleBeilstein journal of nanotechnology2025
Characterization of ZnO nanoparticles synthesized using probiotic
Article in Beilstein journal of nanotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Acute toxicity and physiological responses of silver pompano (Trachinotus Blochii) to green-synthesized ZnO nanoparticles.Fish physiology and biochemistry · 2026Article
- Biosynthesized ZnO nanoparticles enhance salt tolerance in Brassica Napus through antioxidant and gene regulatory pathways.BMC plant biology · 2026Article
- Biogenic synthesis of zinc oxide nanoparticles usingBiotechnology notes (Amsterdam, Netherlands) · 2026Article
- Structural, morphological, dielectric and semiconducting properties of ZnO nanoparticles calcined at 500 °C.RSC advances · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The fundamental goal of our investigation is to employ a sustainable synthesis method for zinc oxide nanoparticles (ZnO NPs), utilizing lactic acid bacteria isolated from curd as the key biological agent. Bacteria function as agents for both reduction and capping processes, which aids the synthesis of ZnO NPs. Various characterization techniques including XRD, FTIR, UV-vis, TEM, SEM-EDX, and zeta potential measurements were employed to analyze the morphology, dimensions, and elemental composition of the generated nanoparticles. The experimental outcomes confirmed the presence of hexagonal wurtzite-structured ZnO NPs with an average size of 10 nm. The colloidal system demonstrated excellent stability with a zeta potential of -60 mV. Furthermore, the synthesized nanoparticles displayed significant antibacterial activity against selected human pathogens, with the biggest inhibition zone observed against
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.